Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1990 1
1991 1
1992 1
1995 1
1996 1
1997 1
1998 1
1999 4
2000 1
2001 2
2002 6
2003 9
2004 7
2005 11
2006 12
2007 8
2008 5
2009 4
2010 1
2011 5
2013 1
2014 4
2015 3
2016 3
2017 4
2018 1
2019 3
2020 6
2021 3
2022 7
2023 9
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial.
Gogishvili M, Melkadze T, Makharadze T, Giorgadze D, Dvorkin M, Penkov K, Laktionov K, Nemsadze G, Nechaeva M, Rozhkova I, Kalinka E, Gessner C, Moreno-Jaime B, Passalacqua R, Li S, McGuire K, Kaul M, Paccaly A, Quek RGW, Gao B, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Gullo G, Rietschel P. Gogishvili M, et al. Among authors: gessner c. Nat Med. 2022 Nov;28(11):2374-2380. doi: 10.1038/s41591-022-01977-y. Epub 2022 Aug 25. Nat Med. 2022. PMID: 36008722 Free PMC article. Clinical Trial.
Asthma-Remission als realistisches Ziel.
Lommatzsch M, Gessner C. Lommatzsch M, et al. Among authors: gessner c. MMW Fortschr Med. 2023 Jun;165(11):5. doi: 10.1007/s15006-023-2579-7. MMW Fortschr Med. 2023. PMID: 37258813 German. No abstract available.
Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial.
Martinez FJ, Criner GJ, Gessner C, Jandl M, Scherbovsky F, Shinkai M, Siler TM, Vogelmeier CF, Voves R, Wedzicha JA, Bartels C, Bottoli I, Byiers S, Cardenas P, Eckert JH, Gutzwiller FS, Knorr B, Kothari M, Parlikar R, Tanase AM, Franssen FME. Martinez FJ, et al. Among authors: gessner c. Am J Respir Crit Care Med. 2023 Aug 15;208(4):417-427. doi: 10.1164/rccm.202303-0458OC. Am J Respir Crit Care Med. 2023. PMID: 37411039 Free PMC article. Clinical Trial.
Storylines for unprecedented heatwaves based on ensemble boosting.
Fischer EM, Beyerle U, Bloin-Wibe L, Gessner C, Humphrey V, Lehner F, Pendergrass AG, Sippel S, Zeder J, Knutti R. Fischer EM, et al. Among authors: gessner c. Nat Commun. 2023 Aug 22;14(1):4643. doi: 10.1038/s41467-023-40112-4. Nat Commun. 2023. PMID: 37607932 Free PMC article. Review.
[Asthma: an update of drug therapy in adults].
Gessner C, Lommatzsch M. Gessner C, et al. MMW Fortschr Med. 2023 Jun;165(11):44-49. doi: 10.1007/s15006-023-2652-2. MMW Fortschr Med. 2023. PMID: 37258838 Review. German. No abstract available.
[Tuberculosis and travelling].
Hoheisel G, Vogtmann M, Gessner C, Winkler J, Rodloff AC, Wirtz H. Hoheisel G, et al. Among authors: gessner c. Pneumologie. 2009 Sep;63(9):519-25. doi: 10.1055/s-0029-1214995. Epub 2009 Sep 11. Pneumologie. 2009. PMID: 19750412 Free article. Review. German.
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma.
van Zyl-Smit RN, Chapman KR, Kerstjens HAM, Gessner C, Sagara H, Tanase AM, Hosoe M, Pethe A, Lawrence D, Tillmann HC, D'Andrea P. van Zyl-Smit RN, et al. Among authors: gessner c. J Asthma Allergy. 2023 Jan 20;16:123-134. doi: 10.2147/JAA.S392975. eCollection 2023. J Asthma Allergy. 2023. PMID: 36714049 Free PMC article. Review.
The Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
Gillissen A, Haidl P, Khlhäufl M, Kroegel K, Voshaar T, Gessner C. Gillissen A, et al. Among authors: gessner c. Dtsch Arztebl Int. 2016 May 6;113(18):311-6. doi: 10.3238/arztebl.2016.0311. Dtsch Arztebl Int. 2016. PMID: 27215595 Free PMC article. Review.
Quality of life with cemiplimab plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: Patient-reported outcomes from phase 3 EMPOWER-Lung 3.
Makharadze T, Quek RGW, Melkadze T, Gogishvili M, Ivanescu C, Giorgadze D, Dvorkin M, Penkov K, Laktionov K, Nemsadze G, Nechaeva M, Rozhkova I, Kalinka E, Gessner C, Moreno-Jaime B, Passalacqua R, Konidaris G, Rietschel P, Gullo G. Makharadze T, et al. Among authors: gessner c. Cancer. 2023 Jul 15;129(14):2256-2265. doi: 10.1002/cncr.34687. Epub 2023 May 8. Cancer. 2023. PMID: 37151113 Clinical Trial.
Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19.
Al-Saleem J, Granet R, Ramakrishnan S, Ciancetta NA, Saveson C, Gessner C, Zhou Q. Al-Saleem J, et al. Among authors: gessner c. J Chem Inf Model. 2021 Aug 23;61(8):4058-4067. doi: 10.1021/acs.jcim.1c00642. Epub 2021 Jul 23. J Chem Inf Model. 2021. PMID: 34297570 Free article.
120 results